Evolus (EOLS) Invested Capital (2017 - 2026)
Evolus (EOLS) reported Invested Capital of $125.84 million for Q2 2026, down 0.8% from $126.82 million a year earlier and down 1.4% from the prior quarter.
Powered by 
Analysis
Evolus (EOLS) Invested Capital (2017 - 2026) Analysis & Trends
For FY2025, Evolus posted Invested Capital of $122.99 million, down 3.2% from FY2024.
- Invested Capital has a five-year compound annual growth rate of 43.1% (FY2020 to FY2025).
- By year, Invested Capital came in at $127.03 million in FY2024 (+27.4%), $99.67 million in FY2023 (+10.3%), $90.38 million in FY2022 (-41.0%) and $153.1 million in FY2021 (+647.0%).
- Five-year quarterly Invested Capital spans a low of $75.73 million in Q3 2023 and a high of $153.1 million in Q4 2021.
- Year over year, Invested Capital gained in three of the last eight quarters, with growth averaging 8.4%.
- The high point for year-over-year Invested Capital in five years was Q4 2021 (growth of 647.0%); the low point was Q1 2023 (a decline of 43.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $127.63 million (Q1 2026), $122.99 million (Q4 2025) and $117.02 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 134.01 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 64.89 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 95.89 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 79.44 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 50.26 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 68.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 38.08 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 148.69 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Evolus | 528.11 Mn | 335.80 Mn | 57.18 Mn | 125.84 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 125.84 Mn |
| Mar 31, 2026 | 127.63 Mn |
| Dec 31, 2025 | 122.99 Mn |
| Sep 30, 2025 | 117.02 Mn |
| Jun 30, 2025 | 126.82 Mn |
| Mar 31, 2025 | 115.20 Mn |
| Dec 31, 2024 | 127.03 Mn |
| Sep 30, 2024 | 127.10 Mn |
| Jun 30, 2024 | 140.23 Mn |
| Mar 31, 2024 | 139.08 Mn |
| Dec 31, 2023 | 99.67 Mn |
| Sep 30, 2023 | 75.73 Mn |
| Jun 30, 2023 | 87.87 Mn |
| Mar 31, 2023 | 79.00 Mn |
| Dec 31, 2022 | 90.38 Mn |
| Sep 30, 2022 | 100.93 Mn |
| Jun 30, 2022 | 118.41 Mn |
| Mar 31, 2022 | 138.63 Mn |
| Dec 31, 2021 | 153.10 Mn |
| Sep 30, 2021 | 117.35 Mn |
API Access
Evolus Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=EOLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "EOLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=EOLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();